Overview

Detailed Summary

Rainbow Children's Medicare Limited is a leading pediatric and obstetrics healthcare provider in India, operating 23 hospitals across 9 cities. Its network includes pediatric, neonatal, and perinatal care services, with a doctor engagement model that ensures 24/7 care by full-time specialists.
The company has seen a steady improvement in operational metrics, with a 12% revenue growth in Q3 FY26. Its focus on capacity expansion has resulted in new facilities in regions like Rajahmundry and Bengaluru, bolstering its presence in Southern India.
Significant emphasis is on building comprehensive pediatric care with synergies between pediatric and perinatal services. The hub-and-spoke operating model facilitates extensive regional coverage, offering tertiary and quaternary care in central hubs.
Rainbow's strategic plans involve further digital transformation initiatives aimed at enhancing patient engagement and experience. This is aligned with their goal to provide a seamless healthcare journey, integrating digital tools for better accessibility and efficiency.
The recent onboarding of Mr. Abrarali Dalal as the Group CEO is expected to drive the next phase of operational excellence and expansion, leveraging his extensive experience in healthcare to optimize growth and service delivery.

Sector: Healthcare Services
Industry: Hospital
Market Cap: 13,475 Cr
Volatility: Low Risk
P/E Ratio: 48.4
Industry P/E: 59.2
PEG Ratio: 3.2
P/B Ratio: 8.2
52W High: 1,644.10
52W Low: 1,008.75

Sales CAGR

1Y: 16.88%
3Y: 16.30%
5Y: 15.91%
10Y: 22.53%

Profit CAGR

1Y: 11.88%
3Y: 18.64%
5Y: 27.37%
10Y: 33.98%

ROE

TTM: 16.89%
3Y: 17.64%
5Y: 17.48%
10Y: 15.61%

ROCE

TTM: 16.88%
3Y: 18.60%
5Y: 17.90%
10Y: 16.58%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Healthcare Healthcare Healthcare Services Hospital

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
AGARWALEYE		447.75	14,247 Cr	106.97	7.03	0.00	6.58	9.75	4.27
RAINBOW		1320.00	13,472 Cr	48.40	8.17	0.26	16.89	16.88	10.15
PARKHOSPS		293.60	12,628 Cr	49.79	6.28	0.00	12.77	17.33	9.55
HCG		635.90	9,464 Cr	687.76	7.10	0.00	2.90	7.81	0.58
JLHL		1334.85	8,763 Cr	45.17	5.68	0.07	12.56	13.77	8.15
YATHARTH		840.00	8,081 Cr	45.88	4.54	0.00	9.85	11.09	7.50
KOVAI		5748.75	6,289 Cr	25.73	4.77	0.26	18.53	20.76	11.83
Median: 7 Co.	—	840.00	9,464 Cr	48.40	6.28	0.00	12.56	13.77	8.15

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	336	341	330	417	398	370	353	445	445	460
Expenses	218	236	237	270	264	255	249	296	298	315
Operating Profit	118	106	94	147	134	115	104	149	147	145
OPM %	35.15	30.94	28.38	35.23	33.75	31.00	29.36	33.47	33.00	31.46
Other Income	8.61	13	12	11	13	15	20	8.20	11	3.52
Interest	14	17	18	18	18	18	18	19	20	21
Depreciation	28	32	34	35	35	34	34	36	40	41
Profit Before Tax	85	69	53	105	94	77	71	102	98	87
Tax %	26.18	26.18	25.55	25.01	26.92	26.53	24.62	26.13	24.36	9.87
Net Profit	63	51	40	79	69	57	54	76	74	78
EPS in Rs	6.12	5.02	3.89	7.77	6.76	5.55	5.27	7.41	7.14	7.59

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	321	402	543	719	650	974	1,174	1,297	1,516	1,539
Expenses	268	335	394	522	487	669	777	868	1,026	1,039
Operating Profit	53	67	149	197	163	305	396	429	490	500
OPM %	16.48	16.68	27.36	27.39	25.05	31.31	33.78	33.07	32.32	32.48
Other Income	11	9.60	8.35	10	10	19	31	37	51	59
Interest	0.89	1.88	39	45	44	53	55	59	72	72
Depreciation	22	28	60	69	73	83	90	112	138	138
Profit Before Tax	41	47	58	93	56	187	282	295	330	348
Tax %	24.00	22.27	22.49	40.72	28.96	25.98	24.63	25.96	25.99	25.78
Net Profit	31	36	45	55	40	139	212	218	244	258
EPS in Rs	—	—	—	—	—	14.28	20.88	21.37	23.97	27.41
Dividend Payout %	36.87	12.76	21.10	33.78	0.00	13.84	14.36	14.03	12.58	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.28	9.28	44	44	44	44	94	102	102	102
Reserves	275	308	307	317	351	391	498	958	1,157	1,367
Borrowings	21	26	23	476	501	529	592	570	765	764
Other Liabilities	44	55	73	89	124	116	112	140	146	145
Total Liabilities	349	399	448	926	1,019	1,081	1,296	1,771	2,170	2,377
Fixed Assets	123	174	296	702	702	772	858	931	1,253	1,398
CWIP	31	7.34	12	23	43	29	5.76	23	20	28
Investments	1.55	5.51	0.14	3.19	9.90	18	22	58	308	571
Other Assets	194	212	140	199	265	262	409	759	590	380
Total Assets	349	399	448	926	1,019	1,081	1,296	1,771	2,170	2,377

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	17	36	48	127	170	143	224	329	321	396
Cash from Investing Activity	-107	-33	-42	-117	-117	-83	-175	-465	-226	-268
Cash from Financing Activity	93	-1.11	-7.48	-8.69	-52	-61	-44	143	-102	-118
Net Cash Flow	2.88	1.08	-1.93	1.66	1.56	-1.04	4.32	6.99	-6.85	10

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	49.83%	49.83%	49.83%	49.83%	49.88%	49.85%	49.85%	49.85%	49.85%	49.85%	49.86%	49.90%
FIIs	20.19%	21.63%	22.32%	24.04%	24.78%	25.11%	25.12%	23.69%	23.59%	21.85%	19.24%	17.26%
DIIs	15.35%	15.40%	15.62%	14.76%	13.80%	13.83%	13.87%	15.31%	15.44%	17.46%	19.49%	21.16%
Public	14.63%	13.14%	12.23%	11.37%	11.54%	11.20%	11.16%	11.14%	11.11%	10.84%	11.40%	11.69%
Total Shareholders	74,690	79,187	80,471	77,152	78,557	77,524	78,764	79,092	80,320	81,134	88,809	88,561

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan